GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Current Accrued Expense

SXTC (China SXT Pharmaceuticals) Current Accrued Expense : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Current Accrued Expense?

China SXT Pharmaceuticals's Current Accrued Expense for the quarter that ended in Sep. 2024 was $0.00 Mil.

China SXT Pharmaceuticals's quarterly Current Accrued Expense increased from Sep. 2023 ($1.11 Mil) to Mar. 2024 ($1.23 Mil) but then declined from Mar. 2024 ($1.23 Mil) to Sep. 2024 ($0.00 Mil).

China SXT Pharmaceuticals's annual Current Accrued Expense increased from Mar. 2022 ($0.85 Mil) to Mar. 2023 ($0.95 Mil) and increased from Mar. 2023 ($0.95 Mil) to Mar. 2024 ($1.23 Mil).

China SXT Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for China SXT Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Current Accrued Expense Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Current Accrued Expense
Get a 7-Day Free Trial 0.52 0.70 0.85 0.95 1.23

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.95 1.11 1.23 -

China SXT Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

China SXT Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Current Accrued Expense
Comparable Companies
MRMD RMTI SCYX ETST CTOR INIS DRRX CYTH RSCI IXHL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
2RY:Germany
Address
No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
Website
http://www.sxtchina.com
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.